Assignee
CORTEX PHARMA INC
US·7 granted patents·2 pending applications·253 citations·filing 1994–2008
Top patents by PatentIndex Score
9 records- 0192US8013003B2Di-substituted amides for enhancing glutamatergic synaptic responsesCORTEX PHARMA INC·Filed 2008·Granted Sep 6, 2011·21 cites·21 claims
- 0292US5567724AAlkaline and acid phosphatase inhibitors in treatment of neurological disordersCORTEX PHARMA INC·Filed 1994·Granted Oct 22, 1996·118 cites·19 claims
- 0378US6166008ATreatment of schizophrenia with ampakines and neurolepticsCORTEX PHARMA INC·Filed 1998·Granted Dec 26, 2000·42 cites·26 claims
- 0477US5650409ABenzoyl piperidines/pyrrolidines for enhancing synaptic responseCORTEX PHARMA INC·Filed 1995·Granted Jul 22, 1997·44 cites·12 claims
- 0560US7799913B2Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responsesCORTEX PHARMA INC·Filed 2002·Granted Sep 21, 2010·2 cites·47 claims
- 0656US5985871ABenzoxazine compounds for enhancing synaptic responseCORTEX PHARMA INC·Filed 1997·Granted Nov 16, 1999·15 cites·41 claims
- 0749US2010267728A13-substituted-1,2,3-triazin-4-one's and 3 substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responsesCORTEX PHARMA INC·Filed 2008·Application pending·0 cites
- 0848US5622981AUse of metabotropic receptor agonists in progressive neurodegenerative diseasesCORTEX PHARMA INC·Filed 1995·Granted Apr 22, 1997·11 cites·18 claims
- 0945US2010041647A13-Substituted-[1,2,3]-Benzotriazinone compounds for enhancing glutamatergic synaptic responsesCORTEX PHARMA INC·Filed 2007·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →